Nastassia Samal/iStock via Getty Images Regeneron (NASDAQ:REGN) reported positive Phase 2 data for its thrombosis
Michael M. Santiago/Getty Images News California Gov. Gavin Newsom (Dem.) on Wednesday declared a State
Summary: Pfizer Inc.’s technical indicators have shifted from bullish to bearish, with the stock now
Summary: Pfizer Inc.’s share price has declined significantly in each of the past three years,
Jeenah Moon/Getty Images News Pfizer (NYSE:PFE) shares traded higher in the premarket on Tuesday after
Hailshadow/iStock via Getty Images Sangamo Therapeutics (NASDAQ:SGMO) rocketed 24% higher after a report that Roche
Summary: Pfizer’s shares have significantly underperformed, but the current valuation and high dividend yield present
Summary: Pfizer’s stock has become appealing due to irrational vaccine fears. Market fears about RFK
Pfizer (NYSE:PFE) declares $0.43/share quarterly dividend, 2.4% increase from prior dividend of $0.42. Forward yield
georgeclerk Pfizer (NYSE:PFE) said a Phase 3 study of its drug Ibrance in combination with